ALGS Aligos Therapeutics, Inc.
$5.22▼ -2.06%
Healthcare
Other
After hours
$5.20▼ -0.38%
Sep 11, 7:30 PM ET
Volume 36.9K
Avg Volume (10D) 58.0K
Key Metrics & Fundamentals
Market Cap
$32.60M
P/E Ratio
–
Div Yield
–%
52W Range
3.98 - 13.69
% vs 50 MA
-11.69%
% vs 200 MA
-26.30%
RSI-14
37.9
MACD Histogram
-0.2100
Beta (1Y vs SPY)
1.42
Free Cash Flow
-$24.95M
Gross Rev
$27.78M
Gross Profit
$27.78M
EBITDA
-$4.14M
COGS
–
Operating Exp
$29.67M
Operating Income
-$1.89M
EBIT
-$1.89M
Pretax Income
$1.31M
Net Income
-$1.50M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
GlobeNewswire · Sep 2, 2026 12:00 PM
Aligos Therapeutics Shares Rise 7.6% Premarket Following Recent Company Updates
InvestorsHub · Sep 2, 2026 10:45 AM
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
GlobeNewswire · Aug 12, 2026 8:05 PM
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
GlobeNewswire · Aug 6, 2026 12:00 PM
Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
GlobeNewswire · Jul 30, 2026 12:00 PM
Aligos Therapeutics Completes Enrollment in Phase 2 Study of Potential Chronic Hepatitis B Treatment
MT Newswires · Jul 13, 2026 12:33 PM
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
GlobeNewswire · Jul 13, 2026 12:00 PM
ALGS Stock Rallies 16% After-Hours On $25M Cash Boost From China Hepatitis B Drug Deal
Stocktwits · Jul 6, 2026 11:50 PM
Aligos Gets $25 Million Upfront Payment From Licensing Deal
MT Newswires · Jul 6, 2026 8:34 PM
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
GlobeNewswire · Jul 6, 2026 8:05 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ALGS's money flow as a full page
Social Sentiment
No Reddit posts found for ALGS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.